secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aclarion, Inc. (ACON)
CIK:        0001635077
Form:       8-K
Filed at:   2025-01-31T23:59:59+00:00
Accession:  0001683168-25-000627
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aclarion prices $4.7M registered direct offering of 506,803 shares at $9.25 each
--------------------------------------------------------------------------------

- Gross proceeds ~$4.7M; 506,803 shares at $9.25/share; closing expected Jan 31, 2025.
- Net proceeds to fund market development, clinical evidence, product development, and G&A.
- Dawson James Securities serving as sole placement agent; offering under effective S-3 shelf.
- Offering priced at the market; no change to previously announced business plans.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1635077/000168316825000627/0001683168-25-000627-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1635077/000168316825000627/acon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-000627

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer